The activity of thiacetazone, thiambutosine, thiocarlide and sulphamethoxypyridazine against Mycobacterium leprae in mice.

[1]  P. T. Gammon,et al.  Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. , 1978, Leprosy review.

[2]  D. Banerjee,et al.  The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice. , 1978, Leprosy review.

[3]  M. Waters.  The diagnosis and management of dapsone-resistant leprosy. , 1977, Leprosy review.

[4]  R. Rees,et al.  Primary dapsone-resistant leprosy. , 1977, Leprosy review.

[5]  R. Rees,et al.  Dapsone-resistant leprosy and its implications for leprosy control programmes. , 1977, Leprosy review.

[6]  J. Peters,et al.  Susceptibility of Mycobacterium leprae to Dapsone as a Determinant of Patient Response to Acedapsone , 1976, Antimicrobial Agents and Chemotherapy.

[7]  Ellard Ga.  Pharmacological aspects of the chemotherapy of leprosy. , 1975 .

[8]  L. Levy,et al.  Inhibition of multiplication of Mycobacterium leprae by several antithyroid drugs. , 1975, The American review of respiratory disease.

[9]  Shepard Cc.  A survey of the drugs with activity against M. leprae in mice. , 1971 .

[10]  W. Mohr.  Observations on the treatment of leprosy with Lederkyn, DDS and new tuberculostatic substances. , 1971, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[11]  Opromolla Dv.  Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses. , 1971 .

[12]  P. T. Gammon,et al.  The minimal inhibitory concentrations of sulphadimethozine and sulphadoxine against Mycobacterium leprae. , 1970, Leprosy review.

[13]  D. Mitchison,et al.  In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosis , 1966 .

[14]  S. Bushby,et al.  THE RESPONSE TO TREATMENT WITH THIACETAZONE OF GUINEA-PIGS AND MICE INFECTED WITH TUBERCLE BACILLI OBTAINED FROM UNTREATED AFRICAN PATIENTS. , 1963, Tubercle.

[15]  N. Buu‐Hoï,et al.  Résultats à court terme d’un traitement de la lèpre par le 4,4’-diisoamyloxythiocarbanilide , 1961 .

[16]  T. Davey.  Some recent chemotherapeutic work in leprosy: with a discussion of some of the problems involved in clinical trials. , 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  J. Lowe.  The chemotherapy of leprosy: late results of treatment with sulphone, and with thiosemicarbazone. , 1954, Lancet.

[18]  S. G. Browne.  DRUG RESISTANCE IN LEPROSY-MYTH OR MENACE? , 1977 .

[19]  Shepard Cc.  Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice. , 1976 .

[20]  R. Rees,et al.  Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance. , 1976, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[21]  S. Pattyn,et al.  Sensibilité envers la dapsone, la sulfamethoxypyridazine et l'éthionamide, de Mycobacterium leprae provenant de malades traités par ces substances , 1975 .

[22]  S. Pattyn.  Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. , 1973, Leprosy review.

[23]  C. Shepard.  A kinetic method for the study of activity of drugs against Mycobacterium leprae in mice. , 1967 .